SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Silence Therapeutics plc (SLN) News

Follow Silence Therapeutics plc (SLN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SLN Asset equity Sector Markets 90 days 9 Last 19.575 Updated Oct 19, 2026, 01:43 PM UTC Open live news feed Open SLN chart & news
M Merck KGaA to acquire Silence Therapeutics for about $1.3 billion Merck KGaA said it will acquire Silence Therapeutics in an all-cash deal valued at about $1.3 billion. EQUITY | Oct 19, 2026, 01:43 PM UTC M Merck Agrees to Buy Silence Therapeutics for $1.3 Billion Merck KGaA said it is offering $20 per American depositary share in cash for the U.K. biotech, adding an experimental polycythemia vera medicine to its pipeline. MNA | Oct 19, 2026, 12:45 PM UTC M Germany’s Merck to Buy Silence Therapeutics for $20 per ADS in Cash Germany’s Merck is buying U.K.-based Silence Therapeutics for $20 per ADS in cash. MNA | Oct 19, 2026, 12:05 PM UTC M Germany's Merck to Buy Silence Therapeutics for About $1.3B MNA | Oct 19, 2026, 12:04 PM UTC M Silence Therapeutics to Be Acquired for $20 per ADS An all-cash transaction values Silence Therapeutics at about $1.3 billion. MNA | Oct 19, 2026, 12:04 PM UTC M Germany’s Merck to Buy Silence Therapeutics MNA | Oct 19, 2026, 12:03 PM UTC M Merck KGaA to Acquire Silence Therapeutics for $1.3 Billion The companies entered a definitive deal valuing Silence Therapeutics at about $1.3 billion in equity, or $20.00 per ADS. Closing is expected in Q1 2027, subject to shareholder, Court and regulatory approvals. EQUITY | Oct 19, 2026, 12:01 PM UTC M Silence Therapeutics Agrees to Be Acquired by Merck KGaA MNA | Oct 19, 2026, 12:00 PM UTC L Silence Therapeutics management to participate in September investor conferences Silence Therapeutics plc said management will participate in three September investor conferences, with invited investors able to join via webcast. EQUITY | Sep 02, 2026, 12:00 PM UTC